JANX - Janux Therapeutics, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.65
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$45.17
DETAILS
HIGH:
$72.00
LOW:
$29.00
MEDIAN:
$41.50
CONSENSUS:
$45.17
UPSIDE:
230.92%
Market Cap:
821.02M
Volume:
723,414
Avg Volume:
2,152,598
52 Week Range:
12.12-36.25
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.87
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
91
IPO Date:
2021-06-11
EPS (TTM):
-1.28
P/E Ratio:
-41.71
Revenue (TTM):
10.59M
Total Assets:
1.06B
Total Debt:
23.02M
Cash & Equiv:
430.61M
Rev Growth (5Y):
42.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-9.5%
Debt/Equity:
0.02
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.39 | $-0.60 | +35.0% | $10.0M | — | — |
| 2025-08-07 | $-0.55 | $-0.48 | -14.6% | — | $300000 | — |
| 2025-05-08 | $-0.38 | $-0.43 | +11.6% | — | $660000 | — |
| 2025-02-27 | $-0.36 | $-0.49 | +26.5% | — | $1.8M | — |
| 2024-11-06 | $-0.51 | $-0.37 | -37.8% | $439000 | $1.5M | -70.6% |
| 2024-08-07 | $-0.11 | $-0.32 | +65.6% | $8.9M | $1.4M | +513.6% |
| 2024-05-07 | $-0.30 | $-0.35 | +14.3% | $1.3M | $660000 | +89.7% |
| 2024-03-08 | $-0.25 | $-0.37 | +32.4% | $2.5M | $740000 | +232.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 10.59M | 8.08M | 8.61M | 3.64M | 0 | 0 |
| Net Income | (68.99M) | (58.29M) | (63.06M) | (32.67M) | (6.78M) | (4.24M) |
| EPS | -1.28 | -1.32 | -1.52 | -0.79 | -0.16 | -0.10 |
| Total Assets | 1.06B | 380.41M | 364.01M | 379.82M | 16.22M | 679,000 |
| Total Debt | 23.02M | 24.54M | 25.30M | 194,000 | 0 | 4.00M |
| Cash & Equivalents | 430.61M | 19.20M | 51.43M | 35.58M | 7.81M | 658,000 |
| Operating Cash Flow | (43.81M) | (50.58M) | (42.92M) | (16.98M) | (4.37M) | (3.83M) |
| Free Cash Flow | (44.17M) | (52.42M) | (49.37M) | (18.46M) | (4.37M) | (3.83M) |
| FCF per Share | -0.82 | -1.19 | -1.19 | -0.45 | -0.10 | -0.09 |
| Book Value | 1.02B | 344.35M | 320.74M | 366.33M | (14.64M) | (7.94M) |
| Cash & ST Investments | 1.03B | 344.03M | 327.02M | 374.96M | 7.81M | 658,000 |
| ROC Equity | -0.07 | -0.17 | -0.20 | -0.09 | N/A | N/A |